• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

Public
DNTH
United States
SectorHealthcare
CountryUnited States
Market cap4.91B
A clinical-stage biotechnology company developing antibody therapies for complement-mediated disorders.

Where to buy Dianthus Therapeutics, Inc. (DNTH)

DNTH trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare